- directed: true
  graph:
    disease: Malignant tumor of colon
    disease_mesh: MESH:D003110
    drug: cetuximab
    drug_mesh: MESH:D000068818
    drugbank: DB:DB00002
  links:
    - key: decreases activity of
      source: MESH:D000068818
      target: UniProt:P00533
    - key: positively regulates
      source: UniProt:P00533
      target: GO:0004697
    - key: positively regulates
      source: GO:0004697
      target: GO:0050673
    - key: negatively regulates
      source: GO:0004697
      target: GO:0006915
    - key: negatively correlated with
      source: GO:0006915
      target: MESH:D003110
    - key: positively correlated with
      source: GO:0050673
      target: MESH:D003110
  multigraph: true
  nodes:
    - id: MESH:D000068818
      label: Drug
      name: cetuximab
    - id: UniProt:P00533
      label: Protein
      name: Epidermal growth factor receptor
    - id: GO:0004697
      label: MolecularActivity
      name: protein kinase C activity
    - id: GO:0050673
      label: BiologicalProcess
      name: epithelial cell proliferation
    - id: GO:0006915
      label: BiologicalProcess
      name: apoptotic process
    - id: MESH:D003110
      label: Disease
      name: Malignant tumor of colon
  reference:
    - https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201577/
    - https://en.wikipedia.org/wiki/Cetuximab#Mechanism_of_action
    - https://en.wikipedia.org/wiki/Epidermal_growth_factor_receptor#Cancer
    - https://en.wikipedia.org/wiki/Colorectal_cancer#Pathogenesis
- directed: true
  graph:
    disease: Renal osteodystrophy
    disease_mesh: MESH:D012080
    drug: calcifediol
    drug_mesh: MESH:D002112
    drugbank: DB:DB00146
  links:
    - key: produces
      source: MESH:D002112
      target: MESH:D002117
    - key: increases activity of
      source: MESH:D002117
      target: UniProt:P11473
    - key: positively regulates
      source: UniProt:P11473
      target: GO:0004498
    - key: positively correlated with
      source: GO:0004498
      target: GO:0055074
    - key: negatively correlated with
      source: GO:0055074
      target: HP:0004363
    - key: superclass of
      source: HP:0004363
      target: HP:0002901
    - key: manifestation of
      source: HP:0002901
      target: MESH:D012080
  multigraph: true
  nodes:
    - id: MESH:D002112
      label: Drug
      name: calcifediol
      alt_names:
        - Calcidiol
        - 25-Hydroxyvitamin D3
        - 25-hydroxycholecalciferol
    - id: MESH:D002117
      label: ChemicalSubstance
      name: calcitriol
    - id: UniProt:P11473
      label: Protein
      name: Vitamin D3 receptor
    - id: GO:0004498
      label: MolecularActivity
      name: calcidiol 1-monooxygenase activity
    - id: GO:0055074
      label: BiologicalProcess
      name: calcium ion homeostasis
    - id: HP:0004363
      label: PhenotypicFeature
      name: Abnormal circulating calcium concentration
    - id: HP:0002901
      label: PhenotypicFeature
      name: Hypocalcemia
    - id: MESH:D012080
      label: Disease
      name: Renal osteodystrophy
  reference:
    - https://en.wikipedia.org/wiki/Calcifediol
    - https://en.wikipedia.org/wiki/Calcitriol#Mechanism_of_action
    - https://go.drugbank.com/drugs/DB00146
    - https://en.wikipedia.org/wiki/Renal_osteodystrophy#Pathogenesis
- directed: true
  graph:
    disease: Hypocalcemia
    disease_mesh: MESH:D006996
    drug: calcifediol
    drug_mesh: MESH:D002112
    drugbank: DB:DB00146
  links:
    - key: produces
      source: MESH:D002112
      target: MESH:D002117
    - key: increases activity of
      source: MESH:D002117
      target: UniProt:P11473
    - key: positively regulates
      source: UniProt:P11473
      target: GO:0004498
    - key: positively correlated with
      source: GO:0004498
      target: GO:0055074
    - key: negatively correlated with
      source: GO:0055074
      target: HP:0004363
    - key: superclass of
      source: HP:0004363
      target: MESH:D006996
  multigraph: true
  nodes:
    - id: MESH:D002112
      label: Drug
      name: calcifediol
      alt_names:
        - Calcidiol
        - 25-Hydroxyvitamin D3
        - 25-hydroxycholecalciferol
    - id: MESH:D002117
      label: ChemicalSubstance
      name: calcitriol
    - id: UniProt:P11473
      label: Protein
      name: Vitamin D3 receptor
    - id: GO:0004498
      label: MolecularActivity
      name: calcidiol 1-monooxygenase activity
    - id: GO:0055074
      label: BiologicalProcess
      name: calcium ion homeostasis
    - id: HP:0004363
      label: PhenotypicFeature
      name: Abnormal circulating calcium concentration
    - id: MESH:D006996
      label: Disease
      name: Hypocalcemia
  reference:
    - https://en.wikipedia.org/wiki/Calcifediol
    - https://en.wikipedia.org/wiki/Calcitriol#Mechanism_of_action
    - https://go.drugbank.com/drugs/DB00146
- directed: true
  graph:
    disease: Hypophosphatemia
    disease_mesh: MESH:D017674
    drug: calcifediol
    drug_mesh: MESH:D002112
    drugbank: DB:DB00146
  links:
    - key: produces
      source: MESH:D002112
      target: MESH:D002117
    - key: increases activity of
      source: MESH:D002117
      target: UniProt:P11473
    - key: positively regulates
      source: UniProt:P11473
      target: GO:0004498
    - key: positively correlated with
      source: GO:0004498
      target: GO:0055074
    - key: positively correlated with
      source: GO:0055074
      target: GO:0055062
    - key: negatively correlated with
      source: GO:0055062
      target: MESH:D017674
  multigraph: true
  nodes:
    - id: MESH:D002112
      label: Drug
      name: calcifediol
      alt_names:
        - Calcidiol
        - 25-Hydroxyvitamin D3
        - 25-hydroxycholecalciferol
    - id: MESH:D002117
      label: ChemicalSubstance
      name: calcitriol
    - id: UniProt:P11473
      label: Protein
      name: Vitamin D3 receptor
    - id: GO:0004498
      label: MolecularActivity
      name: calcidiol 1-monooxygenase activity
    - id: GO:0055074
      label: BiologicalProcess
      name: calcium ion homeostasis
    - id: GO:0055062
      label: BiologicalProcess
      name: phosphate ion homeostasis
    - id: MESH:D017674
      label: Disease
      name: Hypophosphatemia
  reference:
    - https://en.wikipedia.org/wiki/Calcifediol
    - https://en.wikipedia.org/wiki/Calcitriol#Mechanism_of_action
    - https://go.drugbank.com/drugs/DB00146
    - https://en.wikipedia.org/wiki/Hypophosphatemia#Causes
- directed: true
  graph:
    disease: Rickets
    disease_mesh: MESH:D017674
    drug: calcifediol
    drug_mesh: MESH:D002112
    drugbank: DB:DB00146
  links:
    - key: produces
      source: MESH:D002112
      target: MESH:D002117
    - key: increases activity of
      source: MESH:D002117
      target: UniProt:P11473
    - key: positively regulates
      source: UniProt:P11473
      target: GO:0004498
    - key: positively correlated with
      source: GO:0004498
      target: GO:0055074
    - key: positively correlated with
      source: GO:0055074
      target: GO:0030282
    - key: negatively correlated with
      source: GO:0030282
      target: MESH:D017674
  multigraph: true
  nodes:
    - id: MESH:D002112
      label: Drug
      name: calcifediol
      alt_names:
        - Calcidiol
        - 25-Hydroxyvitamin D3
        - 25-hydroxycholecalciferol
    - id: MESH:D002117
      label: ChemicalSubstance
      name: calcitriol
    - id: UniProt:P11473
      label: Protein
      name: Vitamin D3 receptor
    - id: GO:0004498
      label: MolecularActivity
      name: calcidiol 1-monooxygenase activity
    - id: GO:0055074
      label: BiologicalProcess
      name: calcium ion homeostasis
    - id: GO:0030282
      label: BiologicalProcess
      name: bone mineralization
    - id: MESH:D017674
      label: Disease
      name: Rickets
  reference:
    - https://en.wikipedia.org/wiki/Calcifediol
    - https://en.wikipedia.org/wiki/Calcitriol#Mechanism_of_action
    - https://go.drugbank.com/drugs/DB00146
    - https://en.wikipedia.org/wiki/Rickets#Cause
    - https://en.wikipedia.org/wiki/Rickets#Signs_and_symptoms
- directed: true
  graph:
    disease: Osteitis deformans
    disease_mesh: MESH:D010001
    drug: risedronic acid
    drug_mesh: MESH:D000068296
    drugbank: DB:DB00884
  links:
    - key: negatively correlated with
      source: MESH:D000068296
      target: GO:0140603
    - key: increases activity of
      source: GO:0140603
      target: CL:0000092
    - key: negatively regulates
      source: MESH:D000068296
      target: UniProt:P38606
    - key: positively regulates
      source: UniProt:P38606
      target: GO:1902600
    - key: positively correlated with
      source: GO:1902600
      target: GO:0045453
    - key: positively regulates
      source: MESH:D000068296
      target: GO:0006915
    - key: decreases abundance of
      source: GO:0006915
      target: CL:0000092
    - key: positively regulates
      source: CL:0000092
      target: GO:0045453
    - key: positively correlated with
      source: GO:0045453
      target: MESH:D010001
    - key: molecularly interacts with
      source: MESH:D000068296
      target: CHEBI:52255
    - key: positively correlated with
      source: CHEBI:52255
      target: GO:0001503
    - key: positively correlated with
      source: CHEBI:52255
      target: GO:1990523
    - key: negatively correlated with
      source: GO:1990523
      target: MESH:D010001
    - key: negatively correlated with
      source: GO:0001503
      target: MESH:D010001
  multigraph: true
  nodes:
    - id: MESH:D000068296
      label: Drug
      name: risedronic acid
    - id: GO:0140603
      label: MolecularActivity
      name: ATP hydrolysis activity
    - id: UniProt:P38606
      label: Protein
      name: V-type proton ATPase catalytic subunit A
    - id: GO:1902600
      label: BiologicalProcess
      name: proton transmembrane transport
    - id: CHEBI:52255
      label: ChemicalSubstance
      name: hydroxylapatite
    - id: CL:0000092
      label: Cell
      name: osteoclast
    - id: GO:0045453
      label: BiologicalProcess
      name: bone resorption
    - id: GO:0006915
      label: BiologicalProcess
      name: apoptotic process
    - id: GO:0001503
      label: BiologicalProcess
      name: ossification
    - id: GO:1990523
      label: BiologicalProcess
      name: bone regeneration
    - id: MESH:D010001
      label: Disease
      name: Osteitis deformans
      alt_names:
        - Paget's disease of bone
  reference:
    - https://go.drugbank.com/drugs/DB00884
    - https://pubchem.ncbi.nlm.nih.gov/compound/5245#section=Mechanism-of-Action
    - https://en.wikipedia.org/wiki/Paget%27s_disease_of_bone
- directed: true
  graph:
    disease: Osteoporosis
    disease_mesh: MESH:D010024
    drug: risedronic acid
    drug_mesh: MESH:D000068296
    drugbank: DB:DB00884
  links:
    - key: negatively correlated with
      source: MESH:D000068296
      target: GO:0140603
    - key: increases activity of
      source: GO:0140603
      target: CL:0000092
    - key: negatively regulates
      source: MESH:D000068296
      target: UniProt:P38606
    - key: positively regulates
      source: UniProt:P38606
      target: GO:1902600
    - key: positively correlated with
      source: GO:1902600
      target: GO:0045453
    - key: positively regulates
      source: MESH:D000068296
      target: GO:0006915
    - key: decreases abundance of
      source: GO:0006915
      target: CL:0000092
    - key: positively regulates
      source: CL:0000092
      target: GO:0045453
    - key: positively correlated with
      source: GO:0045453
      target: MESH:D010024
    - key: molecularly interacts with
      source: MESH:D000068296
      target: CHEBI:52255
    - key: positively correlated with
      source: CHEBI:52255
      target: GO:0001503
    - key: positively correlated with
      source: CHEBI:52255
      target: GO:1990523
    - key: negatively correlated with
      source: GO:1990523
      target: MESH:D010024
    - key: negatively correlated with
      source: GO:0001503
      target: MESH:D010024
  multigraph: true
  nodes:
    - id: MESH:D000068296
      label: Drug
      name: risedronic acid
    - id: GO:0140603
      label: MolecularActivity
      name: ATP hydrolysis activity
    - id: UniProt:P38606
      label: Protein
      name: V-type proton ATPase catalytic subunit A
    - id: GO:1902600
      label: BiologicalProcess
      name: proton transmembrane transport
    - id: CHEBI:52255
      label: ChemicalSubstance
      name: hydroxylapatite
    - id: CL:0000092
      label: Cell
      name: osteoclast
    - id: GO:0045453
      label: BiologicalProcess
      name: bone resorption
    - id: GO:0006915
      label: BiologicalProcess
      name: apoptotic process
    - id: GO:0001503
      label: BiologicalProcess
      name: ossification
    - id: GO:1990523
      label: BiologicalProcess
      name: bone regeneration
    - id: MESH:D010024
      label: Disease
      name: Osteoporosis
  reference:
    - https://go.drugbank.com/drugs/DB00884
    - https://pubchem.ncbi.nlm.nih.gov/compound/5245#section=Mechanism-of-Action
- directed: true
  graph:
    disease: Postmenopausal osteoporosis
    disease_mesh: MESH:D015663
    drug: risedronic acid
    drug_mesh: MESH:D000068296
    drugbank: DB:DB00884
  links:
    - key: negatively correlated with
      source: MESH:D000068296
      target: GO:0140603
    - key: increases activity of
      source: GO:0140603
      target: CL:0000092
    - key: negatively regulates
      source: MESH:D000068296
      target: UniProt:P38606
    - key: positively regulates
      source: UniProt:P38606
      target: GO:1902600
    - key: positively correlated with
      source: GO:1902600
      target: GO:0045453
    - key: positively regulates
      source: MESH:D000068296
      target: GO:0006915
    - key: decreases abundance of
      source: GO:0006915
      target: CL:0000092
    - key: positively regulates
      source: CL:0000092
      target: GO:0045453
    - key: positively correlated with
      source: GO:0045453
      target: MESH:D015663
    - key: molecularly interacts with
      source: MESH:D000068296
      target: CHEBI:52255
    - key: positively correlated with
      source: CHEBI:52255
      target: GO:0001503
    - key: positively correlated with
      source: CHEBI:52255
      target: GO:1990523
    - key: negatively correlated with
      source: GO:1990523
      target: MESH:D015663
    - key: negatively correlated with
      source: GO:0001503
      target: MESH:D015663
  multigraph: true
  nodes:
    - id: MESH:D000068296
      label: Drug
      name: risedronic acid
    - id: GO:0140603
      label: MolecularActivity
      name: ATP hydrolysis activity
    - id: UniProt:P38606
      label: Protein
      name: V-type proton ATPase catalytic subunit A
    - id: GO:1902600
      label: BiologicalProcess
      name: proton transmembrane transport
    - id: CHEBI:52255
      label: ChemicalSubstance
      name: hydroxylapatite
    - id: CL:0000092
      label: Cell
      name: osteoclast
    - id: GO:0045453
      label: BiologicalProcess
      name: bone resorption
    - id: GO:0006915
      label: BiologicalProcess
      name: apoptotic process
    - id: GO:0001503
      label: BiologicalProcess
      name: ossification
    - id: GO:1990523
      label: BiologicalProcess
      name: bone regeneration
    - id: MESH:D015663
      label: Disease
      name: Postmenopausal osteoporosis
  reference:
    - https://go.drugbank.com/drugs/DB00884
    - https://pubchem.ncbi.nlm.nih.gov/compound/5245#section=Mechanism-of-Action
- directed: true
  graph:
    disease: Hypertensive disorder
    disease_mesh: MESH:D006973
    drug: mecamylamine
    drug_mesh: MESH:D008464
    drugbank: DB:DB00657
  links:
    - key: decreases activity of
      source: MESH:D008464
      target: InterPro:IPR002394
    - key: positively regulates
      source: InterPro:IPR002394
      target: GO:0007271
    - key: positively correlated with
      source: GO:0007271
      target: GO:0006939
    - key: positively correlated with
      source: GO:0006939
      target: GO:0042310
    - key: positively correlated with
      source: GO:0042310
      target: HP:0032263
    - key: manifestation of
      source: HP:0032263
      target: MESH:D006973
  multigraph: true
  nodes:
    - id: MESH:D008464
      label: Drug
      name: mecamylamine
    - id: InterPro:IPR002394
      label: GeneFamily
      name: Nicotinic acetylcholine receptor
    - id: GO:0007271
      label: BiologicalProcess
      name: synaptic transmission, cholinergic
    - id: GO:0006939
      label: BiologicalProcess
      name: smooth muscle contraction
    - id: GO:0042310
      label: BiologicalProcess
      name: vasoconstriction
    - id: HP:0032263
      label: PhenotypicFeature
      name: Increased blood pressure
    - id: MESH:D006973
      label: Disease
      name: Hypertensive disorder
  reference:
    - https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL267936/
    - https://go.drugbank.com/drugs/DB00657
- directed: true
  graph:
    disease: Acute myeloid leukemia, disease
    disease_mesh: MESH:D015470
    drug: daunorubicin
    drug_mesh: MESH:D003630
    drugbank: DB:DB00694
  links:
    - key: contributes to
      source: MESH:D003630
      target: GO:0001207
    - key: negatively correlated with
      source: GO:0001207
      target: GO:0009299
    - key: positively correlated with
      source: GO:0009299
      target: HP:0031377
    - key: negatively regulates
      source: MESH:D003630
      target: GO:0140014
    - key: positively correlated with
      source: GO:0140014
      target: HP:0031377
    - key: decreases abundance of
      source: MESH:D003630
      target: GO:0032993
    - key: has participant
      source: GO:0032993
      target: UniProt:P11388
    - key: has participant
      source: GO:0032993
      target: UniProt:Q02880
    - key: positively correlated with
      source: UniProt:Q02880
      target: GO:0006260
    - key: positively correlated with
      source: UniProt:P11388
      target: GO:0006260
    - key: increases abundance of
      source: MESH:D003630
      target: MESH:D005609
    - key: positively correlated with
      source: MESH:D005609
      target: MESH:D004249
    - key: positively correlated with
      source: MESH:D004249
      target: GO:0006915
    - key: negatively correlated with
      source: GO:0006915
      target: MESH:D015470
    - key: positively correlated with
      source: GO:0006260
      target: HP:0031377
    - key: positively correlated with
      source: GO:0006260
      target: GO:0140014
    - key: positively correlated with
      source: GO:0140014
      target: HP:0031377
    - key: manifestation of
      source: HP:0031377
      target: MESH:D015470
  multigraph: true
  nodes:
    - id: MESH:D003630
      label: Drug
      name: daunorubicin
    - id: GO:0001207
      label: BiologicalProcess
      name: histone displacement
    - id: GO:0009299
      label: BiologicalProcess
      name: mRNA transcription
    - id: UniProt:P11388
      label: Protein
      name: DNA topoisomerase 2-alpha
    - id: UniProt:Q02880
      label: Protein
      name: DNA topoisomerase 2-beta
    - id: GO:0032993
      label: CellularComponent
      name: protein-DNA complex
    - id: MESH:D005609
      label: ChemicalSubstance
      name: Free Radicals
    - id: MESH:D004249
      label: BiologicalProcess
      name: DNA Damage
    - id: GO:0006260
      label: BiologicalProcess
      name: DNA replication
    - id: HP:0031377
      label: PhenotypicFeature
      name: Abnormal cell proliferation
    - id: GO:0006915
      label: BiologicalProcess
      name: apoptotic process
    - id: GO:0140014
      label: BiologicalProcess
      name: mitotic nuclear division
    - id: MESH:D015470
      label: Disease
      name: Acute myeloid leukemia, disease
  reference:
    - https://go.drugbank.com/drugs/DB00694
    - https://en.wikipedia.org/wiki/Daunorubicin#Mechanism_of_action
    - https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL178/
- directed: true
  graph:
    disease: Erythroleukemia, FAB M6
    disease_mesh: MESH:D004915
    drug: daunorubicin
    drug_mesh: MESH:D003630
    drugbank: DB:DB00694
  links:
    - key: contributes to
      source: MESH:D003630
      target: GO:0001207
    - key: negatively correlated with
      source: GO:0001207
      target: GO:0009299
    - key: positively correlated with
      source: GO:0009299
      target: HP:0031377
    - key: negatively regulates
      source: MESH:D003630
      target: GO:0140014
    - key: positively correlated with
      source: GO:0140014
      target: HP:0031377
    - key: decreases abundance of
      source: MESH:D003630
      target: GO:0032993
    - key: has participant
      source: GO:0032993
      target: UniProt:P11388
    - key: has participant
      source: GO:0032993
      target: UniProt:Q02880
    - key: positively correlated with
      source: UniProt:Q02880
      target: GO:0006260
    - key: positively correlated with
      source: UniProt:P11388
      target: GO:0006260
    - key: increases abundance of
      source: MESH:D003630
      target: MESH:D005609
    - key: positively correlated with
      source: MESH:D005609
      target: MESH:D004249
    - key: positively correlated with
      source: MESH:D004249
      target: GO:0006915
    - key: negatively correlated with
      source: GO:0006915
      target: MESH:D004915
    - key: positively correlated with
      source: GO:0006260
      target: HP:0031377
    - key: positively correlated with
      source: GO:0006260
      target: GO:0140014
    - key: positively correlated with
      source: GO:0140014
      target: HP:0031377
    - key: manifestation of
      source: HP:0031377
      target: MESH:D004915
  multigraph: true
  nodes:
    - id: MESH:D003630
      label: Drug
      name: daunorubicin
    - id: GO:0001207
      label: BiologicalProcess
      name: histone displacement
    - id: GO:0009299
      label: BiologicalProcess
      name: mRNA transcription
    - id: UniProt:P11388
      label: Protein
      name: DNA topoisomerase 2-alpha
    - id: UniProt:Q02880
      label: Protein
      name: DNA topoisomerase 2-beta
    - id: GO:0032993
      label: CellularComponent
      name: protein-DNA complex
    - id: MESH:D005609
      label: ChemicalSubstance
      name: Free Radicals
    - id: MESH:D004249
      label: BiologicalProcess
      name: DNA Damage
    - id: GO:0006260
      label: BiologicalProcess
      name: DNA replication
    - id: HP:0031377
      label: PhenotypicFeature
      name: Abnormal cell proliferation
    - id: GO:0006915
      label: BiologicalProcess
      name: apoptotic process
    - id: GO:0140014
      label: BiologicalProcess
      name: mitotic nuclear division
    - id: MESH:D004915
      label: Disease
      name: Erythroleukemia, FAB M6
  reference:
    - https://go.drugbank.com/drugs/DB00694
    - https://en.wikipedia.org/wiki/Daunorubicin#Mechanism_of_action
    - https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL178/
    - https://pubmed.ncbi.nlm.nih.gov/6380596/
- directed: true
  graph:
    disease: Acute monocytic/monoblastic leukemia
    disease_mesh: MESH:D007948
    drug: daunorubicin
    drug_mesh: MESH:D003630
    drugbank: DB:DB00694
  links:
    - key: contributes to
      source: MESH:D003630
      target: GO:0001207
    - key: negatively correlated with
      source: GO:0001207
      target: GO:0009299
    - key: positively correlated with
      source: GO:0009299
      target: HP:0031377
    - key: negatively regulates
      source: MESH:D003630
      target: GO:0140014
    - key: positively correlated with
      source: GO:0140014
      target: HP:0031377
    - key: decreases abundance of
      source: MESH:D003630
      target: GO:0032993
    - key: has participant
      source: GO:0032993
      target: UniProt:P11388
    - key: has participant
      source: GO:0032993
      target: UniProt:Q02880
    - key: positively correlated with
      source: UniProt:Q02880
      target: GO:0006260
    - key: positively correlated with
      source: UniProt:P11388
      target: GO:0006260
    - key: increases abundance of
      source: MESH:D003630
      target: MESH:D005609
    - key: positively correlated with
      source: MESH:D005609
      target: MESH:D004249
    - key: positively correlated with
      source: MESH:D004249
      target: GO:0006915
    - key: negatively correlated with
      source: GO:0006915
      target: MESH:D007948
    - key: positively correlated with
      source: GO:0006260
      target: HP:0031377
    - key: positively correlated with
      source: GO:0006260
      target: GO:0140014
    - key: positively correlated with
      source: GO:0140014
      target: HP:0031377
    - key: manifestation of
      source: HP:0031377
      target: MESH:D007948
  multigraph: true
  nodes:
    - id: MESH:D003630
      label: Drug
      name: daunorubicin
    - id: GO:0001207
      label: BiologicalProcess
      name: histone displacement
    - id: GO:0009299
      label: BiologicalProcess
      name: mRNA transcription
    - id: UniProt:P11388
      label: Protein
      name: DNA topoisomerase 2-alpha
    - id: UniProt:Q02880
      label: Protein
      name: DNA topoisomerase 2-beta
    - id: GO:0032993
      label: CellularComponent
      name: protein-DNA complex
    - id: MESH:D005609
      label: ChemicalSubstance
      name: Free Radicals
    - id: MESH:D004249
      label: BiologicalProcess
      name: DNA Damage
    - id: GO:0006260
      label: BiologicalProcess
      name: DNA replication
    - id: HP:0031377
      label: PhenotypicFeature
      name: Abnormal cell proliferation
    - id: GO:0006915
      label: BiologicalProcess
      name: apoptotic process
    - id: GO:0140014
      label: BiologicalProcess
      name: mitotic nuclear division
    - id: MESH:D007948
      label: Disease
      name: Acute monocytic/monoblastic leukemia
  reference:
    - https://go.drugbank.com/drugs/DB00694
    - https://en.wikipedia.org/wiki/Daunorubicin#Mechanism_of_action
    - https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL178/
    - https://pubmed.ncbi.nlm.nih.gov/6380596/
- directed: true
  graph:
    disease: Acute promyelocytic leukemia, FAB M3
    disease_mesh: MESH:D015473
    drug: daunorubicin
    drug_mesh: MESH:D003630
    drugbank: DB:DB00694
  links:
    - key: contributes to
      source: MESH:D003630
      target: GO:0001207
    - key: negatively correlated with
      source: GO:0001207
      target: GO:0009299
    - key: positively correlated with
      source: GO:0009299
      target: HP:0031377
    - key: negatively regulates
      source: MESH:D003630
      target: GO:0140014
    - key: positively correlated with
      source: GO:0140014
      target: HP:0031377
    - key: decreases abundance of
      source: MESH:D003630
      target: GO:0032993
    - key: has participant
      source: GO:0032993
      target: UniProt:P11388
    - key: has participant
      source: GO:0032993
      target: UniProt:Q02880
    - key: positively correlated with
      source: UniProt:Q02880
      target: GO:0006260
    - key: positively correlated with
      source: UniProt:P11388
      target: GO:0006260
    - key: increases abundance of
      source: MESH:D003630
      target: MESH:D005609
    - key: positively correlated with
      source: MESH:D005609
      target: MESH:D004249
    - key: positively correlated with
      source: MESH:D004249
      target: GO:0006915
    - key: negatively correlated with
      source: GO:0006915
      target: MESH:D015473
    - key: positively correlated with
      source: GO:0006260
      target: HP:0031377
    - key: positively correlated with
      source: GO:0006260
      target: GO:0140014
    - key: positively correlated with
      source: GO:0140014
      target: HP:0031377
    - key: manifestation of
      source: HP:0031377
      target: MESH:D015473
  multigraph: true
  nodes:
    - id: MESH:D003630
      label: Drug
      name: daunorubicin
    - id: GO:0001207
      label: BiologicalProcess
      name: histone displacement
    - id: GO:0009299
      label: BiologicalProcess
      name: mRNA transcription
    - id: UniProt:P11388
      label: Protein
      name: DNA topoisomerase 2-alpha
    - id: UniProt:Q02880
      label: Protein
      name: DNA topoisomerase 2-beta
    - id: GO:0032993
      label: CellularComponent
      name: protein-DNA complex
    - id: MESH:D005609
      label: ChemicalSubstance
      name: Free Radicals
    - id: MESH:D004249
      label: BiologicalProcess
      name: DNA Damage
    - id: GO:0006260
      label: BiologicalProcess
      name: DNA replication
    - id: HP:0031377
      label: PhenotypicFeature
      name: Abnormal cell proliferation
    - id: GO:0006915
      label: BiologicalProcess
      name: apoptotic process
    - id: GO:0140014
      label: BiologicalProcess
      name: mitotic nuclear division
    - id: MESH:D015473
      label: Disease
      name: Acute promyelocytic leukemia, FAB M3
  reference:
    - https://go.drugbank.com/drugs/DB00694
    - https://en.wikipedia.org/wiki/Daunorubicin#Mechanism_of_action
    - https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL178/
    - https://pubmed.ncbi.nlm.nih.gov/6380596/
- directed: true
  graph:
    disease: Kaposi's sarcoma
    disease_mesh: MESH:D012514
    drug: daunorubicin
    drug_mesh: MESH:D003630
    drugbank: DB:DB00694
  links:
    - key: contributes to
      source: MESH:D003630
      target: GO:0001207
    - key: negatively correlated with
      source: GO:0001207
      target: GO:0009299
    - key: positively correlated with
      source: GO:0009299
      target: HP:0031377
    - key: negatively regulates
      source: MESH:D003630
      target: GO:0140014
    - key: positively correlated with
      source: GO:0140014
      target: HP:0031377
    - key: decreases abundance of
      source: MESH:D003630
      target: GO:0032993
    - key: has participant
      source: GO:0032993
      target: UniProt:P11388
    - key: has participant
      source: GO:0032993
      target: UniProt:Q02880
    - key: positively correlated with
      source: UniProt:Q02880
      target: GO:0006260
    - key: positively correlated with
      source: UniProt:P11388
      target: GO:0006260
    - key: increases abundance of
      source: MESH:D003630
      target: MESH:D005609
    - key: positively correlated with
      source: MESH:D005609
      target: MESH:D004249
    - key: positively correlated with
      source: MESH:D004249
      target: GO:0006915
    - key: negatively correlated with
      source: GO:0006915
      target: MESH:D012514
    - key: positively correlated with
      source: GO:0006260
      target: HP:0031377
    - key: positively correlated with
      source: GO:0006260
      target: GO:0140014
    - key: positively correlated with
      source: GO:0140014
      target: HP:0031377
    - key: manifestation of
      source: HP:0031377
      target: MESH:D012514
  multigraph: true
  nodes:
    - id: MESH:D003630
      label: Drug
      name: daunorubicin
    - id: GO:0001207
      label: BiologicalProcess
      name: histone displacement
    - id: GO:0009299
      label: BiologicalProcess
      name: mRNA transcription
    - id: UniProt:P11388
      label: Protein
      name: DNA topoisomerase 2-alpha
    - id: UniProt:Q02880
      label: Protein
      name: DNA topoisomerase 2-beta
    - id: GO:0032993
      label: CellularComponent
      name: protein-DNA complex
    - id: MESH:D005609
      label: ChemicalSubstance
      name: Free Radicals
    - id: MESH:D004249
      label: BiologicalProcess
      name: DNA Damage
    - id: GO:0006260
      label: BiologicalProcess
      name: DNA replication
    - id: HP:0031377
      label: PhenotypicFeature
      name: Abnormal cell proliferation
    - id: GO:0006915
      label: BiologicalProcess
      name: apoptotic process
    - id: GO:0140014
      label: BiologicalProcess
      name: mitotic nuclear division
    - id: MESH:D012514
      label: Disease
      name: Kaposi's sarcoma
  reference:
    - https://go.drugbank.com/drugs/DB00694
    - https://en.wikipedia.org/wiki/Daunorubicin#Mechanism_of_action
    - https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL178/
    - https://pubmed.ncbi.nlm.nih.gov/6380596/
- directed: true
  graph:
    disease: Hypertensive disorder
    disease_mesh: MESH:D006973
    drug: methyldopa
    drug_mesh: MESH:D008750
    drugbank: DB:DB00968
  links:
    - key: has metabolite
      source: MESH:D008750
      target: CHEBI:141146
    - key: increases activity of
      source: CHEBI:141146
      target: UniProt:P08913
    - key: increases activity of
      source: CHEBI:141146
      target: UniProt:P18089
    - key: increases activity of
      source: CHEBI:141146
      target: UniProt:P18825
    - key: negatively regulates
      source: UniProt:P08913
      target: GO:0048242
    - key: negatively regulates
      source: UniProt:P18089
      target: GO:0048242
    - key: negatively regulates
      source: UniProt:P18825
      target: GO:0048242
    - key: negatively regulates
      source: UniProt:P08913
      target: GO:0048243
    - key: negatively regulates
      source: UniProt:P18089
      target: GO:0048243
    - key: negatively regulates
      source: UniProt:P18825
      target: GO:0048243
    - key: positively correlated with
      source: GO:0048242
      target: GO:0042310
    - key: positively correlated with
      source: GO:0048243
      target: GO:0042310
    - key: positively correlated with
      source: GO:0042310
      target: HP:0032263
    - key: manifestation of
      source: HP:0032263
      target: MESH:D006973
  multigraph: true
  nodes:
    - id: MESH:D008750
      label: Drug
      name: methyldopa
    - id: CHEBI:141146
      label: ChemicalSubstance
      name: α-methylnoradrenaline
      alt_names:
        - levonordefrin
        - Corbadrine
        - Nordefrin
    - id: UniProt:P08913
      label: Protein
      name: Alpha-2A adrenergic receptor
    - id: UniProt:P18089
      label: Protein
      name: Alpha-2B adrenergic receptor
    - id: UniProt:P18825
      label: Protein
      name: Alpha-2C adrenergic receptor
    - id: GO:0048242
      label: BiologicalProcess
      name: epinephrine secretion
    - id: GO:0048243
      label: BiologicalProcess
      name: norepinephrine secretion
    - id: GO:0042310
      label: BiologicalProcess
      name: vasoconstriction
    - id: HP:0032263
      label: PhenotypicFeature
      name: Increased blood pressure
    - id: MESH:D006973
      label: Disease
      name: Hypertensive disorder
  reference:
    - https://go.drugbank.com/drugs/DB00968
    - https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL459/
    - https://en.wikipedia.org/wiki/Methyldopa#Mechanism_of_action
    - https://pubchem.ncbi.nlm.nih.gov/compound/38853
    - https://en.wikipedia.org/wiki/Corbadrine
    - https://meshb.nlm.nih.gov/record/ui?ui=D008771
    - https://en.wikipedia.org/wiki/Antihypertensive_drug#Alpha-2_adrenergic_receptor_agonists
    - https://en.wikipedia.org/wiki/Adrenaline#Mechanism_of_action
    - https://www.rxlist.com/aldomet-drug.htm#clinpharm
  comment: The active metabolite is an agonist of the presynaptic α2-adrenergic receptor in the CNS. These are inhibitory receptors that when activated cause inhibition of neurotransmitter release, which inhibits vasoconstriction.
- directed: true
  graph:
    disease: Rheumatoid arthritis
    disease_mesh: MESH:D001172
    drug: sodium aurothiomalate
    drug_mesh: MESH:D006052
    drugbank: DB:DB09276
  links:
    - key: negatively regulates
      source: MESH:D006052
      target: GO:0001516
    - key: increases abundance of
      source: GO:0001516
      target: MESH:D011453
    - key: positively correlated with
      source: MESH:D011453
      target: HP:0001369
    - key: superclass of
      source: HP:0001369
      target: MESH:D001172
  multigraph: true
  nodes:
    - id: MESH:D006052
      label: Drug
      name: sodium aurothiomalate
    - id: GO:0001516
      label: BiologicalProcess
      name: prostaglandin biosynthetic process
    - id: MESH:D011453
      label: ChemicalSubstance
      name: Prostaglandins
    - id: HP:0001369
      label: PhenotypicFeature
      name: Arthritis
    - id: MESH:D001172
      label: Disease
      name: Rheumatoid arthritis
  reference: https://go.drugbank.com/drugs/DB09276
  comment: The precise mechanism of action is unknown.
- directed: true
  graph:
    disease: Juvenile rheumatoid arthritis
    disease_mesh: MESH:D001171
    drug: sodium aurothiomalate
    drug_mesh: MESH:D006052
    drugbank: DB:DB09276
  links:
    - key: negatively regulates
      source: MESH:D006052
      target: GO:0001516
    - key: increases abundance of
      source: GO:0001516
      target: MESH:D011453
    - key: positively correlated with
      source: MESH:D011453
      target: HP:0001369
    - key: superclass of
      source: HP:0001369
      target: HP:0001370
    - key: superclass of
      source: HP:0001370
      target: MESH:D001171
  multigraph: true
  nodes:
    - id: MESH:D006052
      label: Drug
      name: sodium aurothiomalate
    - id: GO:0001516
      label: BiologicalProcess
      name: prostaglandin biosynthetic process
    - id: MESH:D011453
      label: ChemicalSubstance
      name: Prostaglandins
    - id: HP:0001369
      label: PhenotypicFeature
      name: Arthritis
    - id: HP:0001370
      label: PhenotypicFeature
      name: Rheumatoid arthritis
    - id: MESH:D001171
      label: Disease
      name: Juvenile rheumatoid arthritis
  reference: https://go.drugbank.com/drugs/DB09276
  comment: The precise mechanism of action is unknown.
- directed: true
  graph:
    disease: Dementia
    disease_mesh: MESH:D003704
    drug: vinpocetine
    drug_mesh: MESH:C013983
    drugbank: DB:DB12131
  links:
    - key: negatively regulates
      source: MESH:C013983
      target: GO:0098703
    - key: positively correlated with
      source: GO:0098703
      target: GO:0051402
    - key: positively correlated with
      source: GO:0051402
      target: MESH:D003704
    - key: disrupts
      source: GO:0098703
      target: GO:0055074
    - key:  negatively correlated with
      source: GO:0055074
      target: MESH:D003704
    - key: negatively regulates
      source: MESH:C013983
      target: Pfam:PF06512
    - key: positively correlated with
      source: Pfam:PF06512
      target: HP:0001250
    - key: decreases abundance of
      source: MESH:C013983
      target: MESH:D005609
    - key: positively correlated with
      source: MESH:D005609
      target: GO:0036475
    - key: positively correlated with
      source: GO:0036475
      target: HP:0001268
    - key: manifestation of
      source: HP:0001268
      target: MESH:D003704
    - key: manifestation of
      source: HP:0001250
      target: MESH:D003704
  multigraph: true
  nodes:
    - id: MESH:C013983
      label: Drug
      name: vinpocetine
    - id: Pfam:PF06512
      label: GeneFamily
      name: Sodium ion transport-associated
    - id: GO:0098703
      label: BiologicalProcess
      name: calcium ion import across plasma membrane
    - id: GO:0055074
      label: BiologicalProcess
      name: calcium ion homeostasis
    - id: GO:0051402
      label: BiologicalProcess
      name: neuron apoptotic process
    - id: MESH:D005609
      label: ChemicalSubstance
      name: Free Radicals
    - id: GO:0036475
      label: BiologicalProcess
      name: neuron death in response to oxidative stress
    - id: HP:0001268
      label: PhenotypicFeature
      name: Mental deterioration
    - id: HP:0001250
      label: PhenotypicFeature
      name: Seizure
    - id: MESH:D003704
      label: Disease
      name: Dementia
  reference:
    - https://en.wikipedia.org/wiki/Vinpocetine#Mechanism_of_action
    - https://pubmed.ncbi.nlm.nih.gov/2146522/
    - https://pubmed.ncbi.nlm.nih.gov/25826483/
    - https://www.alomone.com/article/role-ion-channels-neurodegeneration
    - https://en.wikipedia.org/wiki/Ion_channel_hypothesis_of_Alzheimer%27s_disease
  comment: Vinpocetine is not approved for any therapeutic use in the United States.
- directed: true
  graph:
    disease: Human immunodeficiency virus infection
    disease_mesh: MESH:D015658
    drug: stavudine
    drug_mesh: MESH:D018119
    drugbank: DB:DB00649
  links:
    - key: decreases activity of
      source: MESH:D018119
      target: UniProt:Q72547
    - key: positively regulates
      source: UniProt:Q72547
      target: GO:0003964
    - key: in taxon
      source: GO:0003964
      target: NCBITaxon:11676
    - key: causes
      source: NCBITaxon:11676
      target: MESH:D015658
  multigraph: true
  nodes:
    - id: MESH:D018119
      label: Drug
      name: stavudine
    - id: UniProt:Q72547
      label: Protein
      name: Reverse transcriptase/RNaseH
    - id: GO:0003964
      label: MolecularActivity
      name: RNA-directed DNA polymerase activity
    - id: NCBITaxon:11676
      label: OrganismTaxon
      name: Human immunodeficiency virus 1
    - id: MESH:D015658
      label: Disease
      name: Human immunodeficiency virus infection
  reference: https://go.drugbank.com/drugs/DB00649
- directed: true
  graph:
    disease: Herpes simplex keratitis
    disease_mesh: MESH:D016849
    drug: idoxuridine
    drug_mesh: MESH:D007065
    drugbank: DB:DB00249
  links:
    - key: disrupts
      source: MESH:D007065
      target: CHEBI:16991
    - key: in taxon
      source: CHEBI:16991
      target: NCBITaxon:10299
    - key: causes
      source: NCBITaxon:10299
      target: MESH:D016849
  multigraph: true
  nodes:
    - id: MESH:D007065
      label: Drug
      name: idoxuridine
    - id: CHEBI:16991
      label: ChemicalSubstance
      name: deoxyribonucleic acid
    - id: NCBITaxon:10299
      label: OrganismTaxon
      name: Human alphaherpesvirus 1 strain 17
    - id: MESH:D016849
      label: Disease
      name: Herpes simplex keratitis
  reference:
    - https://go.drugbank.com/drugs/DB00249
    - https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL788/
- directed: true
  graph:
    disease: Neuroblastoma
    disease_mesh: MESH:D009447
    drug: dinutuximab
    drug_mesh: null
    drugbank: DB:DB09077
  links:
    - key: molecularly interacts with
      source: DB:DB09077
      target: CHEBI:28648
    - key: located in
      source: CHEBI:28648
      target: CL:0001063
    - key: location of
      source: CL:0001063
      target: GO:0001913
    - key: location of
      source: CL:0001063
      target: GO:0097278
    - key: negatively correlated with
      source: GO:0001913
      target: MESH:D009447
    - key: negatively correlated with
      source: GO:0097278
      target: MESH:D009447
  multigraph: true
  nodes:
    - id: DB:DB09077
      label: Drug
      name: dinutuximab
    - id: CHEBI:28648
      label: ChemicalSubstance
      name: β-D-GalNAc-(1→4)-[α-Neu5Ac-(2→8)-α-Neu5Ac-(2→3)]-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-Cer
    - id: CL:0001063
      label: Cell
      name: neoplastic cell
    - id: GO:0001913
      label: BiologicalProcess
      name: T cell mediated cytotoxicity
    - id: GO:0097278
      label: BiologicalProcess
      name: complement-dependent cytotoxicity
    - id: MESH:D009447
      label: Disease
      name: Neuroblastoma
  reference:
    - https://go.drugbank.com/drugs/DB00531
    - https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3137342/
    - https://en.wikipedia.org/wiki/Dinutuximab#Pharmacology
